Early research (Phase 1)WithdrawnNCT01320787What this trial is testing18-F-Fluoroacetate as PET Imaging AgentWho this might be right forBrain CancerBreast CancerProstate Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Early research (Phase 1)UnknownNCT05775666What this trial is testingUCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsWho this might be right forSolid Tumor Peking University 87
Early research (Phase 1)Study completedNCT04617314What this trial is testingRC108-ADC in Subjects With Advanced Malignant Solid TumorsWho this might be right forSolid Tumor RemeGen Co., Ltd. 67
Early research (Phase 1)Ended earlyNCT05098405What this trial is testingFirst-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Molecular Partners AG 46
Testing effectiveness (Phase 2)Study completedNCT04082572What this trial is testingPembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid CancersWho this might be right forLocally Advanced Malignant Solid Neoplasm M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT02029001What this trial is testingAdapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentWho this might be right forMalignant Solid Neoplasms Centre Leon Berard 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Looking for participantsNCT07192107What this trial is testingMHB042C in Patients With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Minghui Pharmaceutical (Hangzhou) Ltd 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136What this trial is testingTesting Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00052338What this trial is testingBortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00250978What this trial is testingPh I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)UnknownNCT00003034What this trial is testingONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy RegimenWho this might be right forMalignant Mesothelioma Alfacell 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263What this trial is testingA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsWho this might be right forRecurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249What this trial is testingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 731
Early research (Phase 1)Looking for participantsNCT07660432What this trial is testingSIM0689 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forNeoplasms, Malignant Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Active Not RecruitingNCT03531645What this trial is testingFulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous CarcinomaWho this might be right forMalignant Neoplasms of Female Genital Organs M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395What this trial is testingEvaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Actuate Therapeutics Inc. 100
Not applicableUnknownNCT00264056What this trial is testingEfficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue MetastasesWho this might be right forAdvanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases Fachklinik Hornheide an der Universität Münster 26
Testing effectiveness (Phase 2)Looking for participantsNCT07399769What this trial is testingEfficacy and Safety of MSLN CAR-T in Advanced Malignant TumorsWho this might be right forAdvanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue) Shenzhen University General Hospital 20